Conclusions
From these findings, it can be concluded that sildenafil response in ED patients can be predicted by NPTR monitoring, using the RigiScan device, and ED patients with a RigiScan base or tip rigidity less than 42% cannot be expected to respond well to sildenafil.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.